As your body adjusts to Semaglutide, Tirzepatide, or Retatrutide therapy, appetite becomes more controlled, energy increases, and weight loss progresses at a sustainable pace
(49.9% and 45.6%, respectively)
The preceding Phase 2 trial enrolled 338 adults with a body mass index of at least 30 (or 27 with a weight-related condition) and ran for 48 weeks
Some providers may start at 5 mg if you were on high-dose semaglutide, but 2.5 mg is the conservative and generally recommended approach
At Alloy, compounded tirzepatide is prescribed by menopause-trained physicians who can tailor treatment to your specific tolerance, goals, and body composition, including by starting you at lower doses and adjusting more gradually, where appropriate
The glycine/B12 formulation may offer marginal benefits for muscle preservation, though clinical evidence remains limited